Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
Cancer Cell|April 12, 2017
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory CancersPer Hydbring, Yinan Wang, Anne Fassl, et al.Frontiers in Plant Science|March 9, 2018
Response of Submerged Macrophyte Communities to External and Internal Restoration Measures in North Temperate Shallow LakesSabine Hilt, Marta M Alirangues Nuñez, Elisabeth S Bakker, et al.Journal of Medicinal Chemistry|December 5, 2025
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 InhibitorGary M Gallego, Cynthia Palmer, Suvi Orr, et al.Molecular Cell|April 3, 2020
Cdk1 Controls Global Epigenetic Landscape in Embryonic Stem CellsWojciech Michowski, Joel M Chick, Chen Chu, et al.Cancer Immunology, Immunotherapy : CII|March 20, 2023
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancerLiv Cecilie Vestrheim Thomsen, Alfred Honoré, Lars Anders Rokne Reisæter, et al.Nature|November 13, 2015
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphismDerek A Oldridge, Andrew C Wood, Nina Weichert-Leahey, et al.The Journal of Experimental Medicine|June 27, 2018
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMarc R Mansour, Shuning He, Zhaodong Li, et al.Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.Cancer Cell|March 11, 2025
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safetyCynthia L Palmer, Britton Boras, Bernadette Pascual, et al.Toxins|April 14, 2018
Temperature Effects Explain Continental Scale Distribution of Cyanobacterial ToxinsEvanthia Mantzouki, Miquel Lürling, Jutta Fastner, et al.Pageof 16